The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti vascular endothelial growth factor (VEGF) antibody.